Switzerland Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Switzerland Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Switzerland Cell and Gene Therapy Manufacturing QC Market was valued at USD 23.2 Million in 2024 and is projected to reach USD 54.2 Million by 2028, expanding at a CAGR of 23.7% during the forecast period. Primary forces propelling market growth include increased demand in pharmaceuticals, biotechnology, and agriculture sectors due to advancements in personalized medicine, ensuring superior efficacy and safety profiles. The energy sector also shows promising prospects for QC services, espousing green production and amplifying export potential. Further, there is an emerging trend towards sustainable and technologically efficient manufacturing practices, setting the stage for stellar growth. With its robust healthcare infrastructure and cutting-edge research facilities, Switzerland is strategically positioning itself as a global helm for Cell and Gene Therapy Manufacturing QC services, paving the way for future market expansion amidst increasing global demand.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market Highlights
- By segment, Cell Therapy emerged as the largest Therapy Type in terms of market size in 2024.
- Gene Therapy is anticipated to remain the most attractive Therapy Type segment, recording the fastest growth during the forecast period.
- In 2024, Switzerland accounted for 1.04% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is expected to lead the global cell and gene therapy manufacturing qc market in terms of market size.
- Within Europe, Germany is projected to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
- France is identified as the fastest-growing market in Europe, anticipated to reach USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 23.2 Million |
| Market Size In 2028 | USD 54.2 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 23.7% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Switzerland Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Switzerland Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Switzerland Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
